Connect with us

Latest News

Novak Djokovic Owns A COVID Treatment Firm – Report

Novak Djokovic has been revealed to be a co-founder and majority shareholder of a biotech firm developing a Covid-19 treatment.

Published

on

Novak Djokovic Owns A COVID Treatment Firm - Report

Novak Djokovic, the popular Serbian tennis player has been revealed to be a co-founder and majority shareholder of a biotech firm developing a Covid-19 treatment.

Recall that the World Number one tennis player has been in the news for refusing the COVID-19 vaccination, He was also deported from Australia because he is not vaccinated for the virus.

Ivan Loncarevic, the chief executive officer of the firm QuantBioRes revealed  to Reuters that Novak owns an 80% share in the Danish biotech company

‘He is one of the founders of my company we founded in June 2020,’ He said.

Novak was supposed to defend his Australian Open title in Melbourne earlier this month before he was deported.

The 34-year-old had been given an exemption to play at the tournament, but it later emerged that an error had been made on his entry form and he had appeared at a public event without a mask the day after he claims to have tested positive for Covid-19.

According to the Danish business register, Djokovic and his wife, Jelena, are the majority shareholders at the firm, which employs around 20 staff in Denmark, Slovenia, Australia and Britain.

Mr Loncarevic explained that the company are working on a treatment, not a vaccine, and added: ‘We aim to develop a new technology to fight viruses and resistant bacteria and we decided to use Covid as a showcase.

‘If we succeed with Covid, we will succeed with other viruses.’

QuantBioRes is planning to launch clinical trials in the UK in the summer, the CEO added.

Prior to the recent legal battle with the Australian Immigration over the COVID-19 Vaccine, The Serbian athlete also sparked controversy in summer 2020 when he hosted a charity tennis tournament with little social distancing that led to a Covid outbreak.

He left Australia on Sunday after a last-gasp court bid to stay failed, meaning he missed the opening Grand Slam of the year, where he was targeting a record 21st major title.

The tennis star also faces the prospect of being unable to defend his French Open title after the government there ruled that all athletes will have to be jabbed to compete in sporting events.

Advertisement